| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |